Dana-Farber Cancer Institut, Inc.;PDL Biopharma Inc.
发明人:
Daniel Afar,Kenneth C. Anderson,Yu-Tzu Tai
申请号：
BRPI0716647
公开号：
BRPI0716647A2
申请日:
2007.08.07
申请国别(地区):
BR
年份:
2017
代理人:
摘要：
Composition suitable for treating multiple myeloma in a subject, comprising a therapeutically effective amount of HuLuc63, a therapeutically effective amount of bortezomib, and a pharmaceutically acceptable carrier, wherein said composition is capable of being administered in a single or multiple dose regimen.
